Cancer screenings that utilize blood tests such as for prostate cancer (testing for prostate-specific antigen) have tended to have a lower deficit compared to cancer screenings that involve procedures such as colonoscopy and mammography (4). Here, KLK3 is linked to prostate carcinoma.